Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Viral, Iron Deficiency, adult, Translational Research, elderly, Clinical Research, Plasma Cell Disorders, Chimeric Antigen Receptor (CAR)-T Cell Therapies, GVHD, Diseases, Immune Disorders, Therapies, Immunotherapy, Infectious Diseases, Lymphoid Malignancies, Infusion, Myeloid Malignancies, Technology and Procedures, gene editing, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Viral, Iron Deficiency, adult, Translational Research, elderly, Clinical Research, Plasma Cell Disorders, Chimeric Antigen Receptor (CAR)-T Cell Therapies, GVHD, Diseases, Immune Disorders, Therapies, Immunotherapy, Infectious Diseases, Lymphoid Malignancies, Infusion, Myeloid Malignancies, Technology and Procedures, gene editing, Study Population, Human, Transplantation
Saturday, December 10, 2022: 4:00 PM-5:30 PM
Great Hall AD
(Ernest N. Morial Convention Center)
Moderators:
Damian J. Green, MD, Fred Hutchinson Cancer Research Center
and
Hongtao Liu, MD, PhD, University of Chicago
Disclosures:
Green: BMS: Membership on an entity's Board of Directors or advisory committees, Research Funding; Cellectar Biosciences: Research Funding; GSK: Membership on an entity's Board of Directors or advisory committees; Janssen Biotech: Membership on an entity's Board of Directors or advisory committees, Research Funding; Neoleukin Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Seattle Genetics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Juno Therapeutics: Patents & Royalties, Research Funding; SpringWorks Therapeutics: Research Funding; Legend Biotech: Membership on an entity's Board of Directors or advisory committees. Liu: Agios; Pfizer; Nkarta; CTI Biopharm; Servier: Honoraria, Other: Advisory board meeting ; NGM Biopharma: Consultancy; Miltenyi Biotec: Research Funding; SITC; Academy for Continued Healthcare Learning (ACHL): Honoraria, Other: Speaker/Lecturer.
CAR studies focused on MM and post allo-HCT T cell therapies (DLI, CTL etc.)
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH